Thalidomide 100MG
Ended Awarded Last action
- Contract number
- 36C24526N0383
- Awardee
-
Bristol-Myers Squibb Company UEI UFGKB2B71N12
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $5,814
Award facts
- Contract value 100% obligated
- $5,814.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Memphis, TN 38141, USA
Award details come from SAM.gov/FPDS.
About this award
Bristol-Myers Squibb Company has been awarded a delivery order valued at $5,814.24 for the supply of Thalidomide 100mg under its Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs. The award, issued on March 6, 2026, with completion scheduled for March 11, 2026, represents a firm fixed-price call against the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. This delivery order supports the Veterans Integrated Service Network 5 (VISN 5) and will be performed at the company's facility in Memphis, Tennessee. The contract carries no set-aside designation, reflecting Bristol-Myers Squibb's status as a large biopharmaceutical manufacturer.
This award is part of Bristol-Myers Squibb's broader engagement with the VA healthcare system through its FSS contract (ID: 36F79724D0101), a multiple-award indefinite delivery/indefinite quantity vehicle with a ceiling value of $12.28 billion extending through April 30, 2029. The parent FSS contract encompasses a comprehensive portfolio of pharmaceutical products across multiple therapeutic areas including oncology, immunology, infectious diseases, and cardiology. Since 2022, the Department of Veterans Affairs has issued more than fifty delivery orders to Bristol-Myers Squibb through this FSS vehicle, demonstrating sustained procurement of the company's specialized pharmaceutical products to support the VA's mission of providing advanced medical care to eligible veterans across the Veterans Health Administration network.
Quick answers
Who was awarded contract 36C24526N0383?
36C24526N0383 was awarded to Bristol-Myers Squibb Company by Veterans Integrated Service Network 5 (Veterans Health Administration) on March 6, 2026.
How much is contract 36C24526N0383 worth?
The government has obligated $5,814 on 36C24526N0383.
Is contract 36C24526N0383 an order under another contract?
Yes. 36C24526N0383 is a BPA call under 36F79724D0101-36E79726A0010, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0383 competed?
The extent of competition for 36C24526N0383 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award